Atlas Trials

SHR-1701 for Induction and Consolidation Therapy in Unresectable Stage III Non-Small Cell Lung Cancer

Clinical trial NCT07619911 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07619911
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
NSCLC Stage IIISHR-1701Chemoradiotherapy
Start date
2026-07-01
Primary completion
2028-07-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.